Annual Report 2021

CORPORATE CALENDAR OF 2021 3 The United Laboratories International Holdings Limited Annual Report 2021 • The United Laboratories’ Semaglutide Injection received a notification of acceptance of clinical registration application. • Zhuhai United Laboratories was awarded the title of “Top 10 Enterprise in Pharmaceutical and Healthcare Manufacturing Industry in Zhuhai for 2020” by Zhuhai Industry and Information Technology Bureau. June • The United Laboratories’ insulin aspart injection, insulin aspart 30 injection and insulin aspart API have been approved for commercialization. • The United Laboratories won the honor of “China Top 100 Chemical Pharmaceutical Enterprises” by ranking the 16th. • The United Laboratories (Inner Mongolia) Limited entered into a cooperation framework agreement on veterinary drugs with Zhejiang Apeloa Biotechnology Co., Ltd. July • Zhuhai United Laboratories was awarded “2020 China Pharmaceutical Industry Top 100 Companies” (ranking the 20th) by China National Pharmaceutical Industry Information Center. August • Zhuhai United Laboratories was awarded “Enterprise Management Award” – Outstanding Enterprise for Green Development in the pharmaceutical industry during the “13th Five- Year Plan”. • The United Laboratories’ Memantine Hydrochloride Tablets (specification: 10mg) passed the quality and efficacy consistency evaluation of generic drugs. May